Clinical Study of the Efficacy and Safety of BCD-201 and Keytruda in Subjects With Advanced Melanoma

Clinical trial NCT05986331 · UNKNOWN

Trial details

NCT number: NCT05986331
Sponsor: Biocad
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Melanoma (Skin)

Start date: 2022-07-18
Primary completion: 2023-12-31
Enrollment: 366

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.